J. Haselden

Stephanie Ringeissen, Paul McGill, Brian C Sweatman, 2003, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Development of a multivariate statistical model to predict peroxisome proliferation in the rat, based on urinary 1H-NMR spectral patterns

M. Hodson, S. Connor, B. Sweatman, 2004, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria

Farah El Mazouni, T. Laird, P. Rathod, 2015, Science Translational Medicine.

Minipig and beagle animal model genomes aid species selection in pharmaceutical discovery and development.

Philippe Sanseau, Samiul Hasan, Xin Li, 2013, Toxicology and applied pharmacology.

Optimisation of collection, storage and preparation of rat plasma for 1H NMR spectroscopic analysis in toxicology studies to determine inherent variation in biochemical profiles.

Brian C Sweatman, Susan C Connor, S. Connor, 2002, Journal of pharmaceutical and biomedical analysis.

A Functional Analysis of Mouse Models of Cardiac Disease through Metabolic Profiling*

Kieran Clarke, Julian L Griffin, Brian C Sweatman, 2005, Journal of Biological Chemistry.

Personalized medicine progresses

Andrew W Nicholls, J. Haselden, A. Nicholls, 2006, Nature Medicine.

Sexual dimorphism in urinary metabolite profiles of Han Wistar rats revealed by nuclear-magnetic-resonance-based metabonomics.

E Holmes, J. Nicholson, E. Holmes, 2005, Analytical biochemistry.

Standardisation of Reporting Methods for Metabolic Analyses : A Draft Policy Document from the Standard Metabolic Reporting Structures

John N. Haselden, Svante Wold, Jeremy K. Nicholson, 2005 .

High-resolution magic angle spinning (1)H NMR spectroscopy of intact liver and kidney: optimization of sample preparation procedures and biochemical stability of tissue during spectral acquisition.

E Holmes, J C Lindon, J. Lindon, 2000, Analytical biochemistry.

A human microdose study of the antimalarial drug GSK3191607 in healthy volunteers

Francisco-Javier Gamo, Santiago Ferrer, Stephanie Gresham, 2018, British journal of clinical pharmacology.

Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids.

J. Haselden, R. Plumb, J. Castro-Pérez, 2003, Rapid communications in mass spectrometry : RCM.

Molecular phenotyping of a UK population: defining the human serum metabolome

Douglas B. Kell, Joshua D. Knowles, Ian D. Wilson, 2014, Metabolomics.

An approach for the development and selection of chromatographic methods for high-throughput metabolomic screening of urine by ultra pressure LC-ESI-ToF-MS

John N. Haselden, Julian L. Griffin, J. Griffin, 2009, Metabolomics.

Peak Alignment of Urine NMR Spectra Using Fuzzy Warping

Wen Wu, Beata Walczak, Michael Daszykowski, 2006, J. Chem. Inf. Model..

Molecular phenotyping of a UK population: defining the human serum metabolome

Joshua D. Knowles, D. Kell, R. Goodacre, 2014, Metabolomics.

A gender-specific discriminator in Sprague-Dawley rat urine: the deployment of a metabolic profiling strategy for biomarker discovery and identification.

Robert S Plumb, Julian L Griffin, J. Griffin, 2007, Analytical biochemistry.

An NMR-based metabolic profiling study of inflammatory pain using the rat FCA model

C. Bountra, I. Chessell, C. Bountra, 2007, Metabolomics.

A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria

Farah El Mazouni, T. Laird, P. Rathod, 2015, Science Translational Medicine.

Metabolic Profiling as a Tool for Understanding Mechanisms of Toxicity

J. Haselden, C. Clarke, 2008, Toxicologic pathology.